Taiko Pharmaceutical Co.,Ltd. (TYO:4574)
Japan flag Japan · Delayed Price · Currency is JPY
270.00
+1.00 (0.37%)
Aug 25, 2026, 3:30 PM JST

Taiko Pharmaceutical Cash Flow Statement

Millions JPY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
616958565-3,563-4,869-8,887
Depreciation & Amortization
288265256704737941
Loss (Gain) From Sale of Assets
26262402,430982,456
Loss (Gain) From Sale of Investments
--347-6-19376-60
Other Operating Activities
-18-2171-602-1,101-1,023
Change in Accounts Receivable
-154-23-411-1752,3153,899
Change in Inventory
7057-3015811,2573,222
Change in Accounts Payable
4531-150308-1,177-2,932
Change in Other Net Operating Assets
-186-151-2203670789
Operating Cash Flow
687814362-307-1,994-1,595
Operating Cash Flow Growth
311.38%124.86%----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-327-291-157-97-64-1,476
Sale of Property, Plant & Equipment
---1702-
Cash Acquisitions
-----9-107
Sale (Purchase) of Intangibles
-12-13-30-17-20-124
Investment in Securities
-5004472661,10528385
Other Investing Activities
1-1-845-2-
Investing Cash Flow
-838142-51,166190-1,622

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---500-5,000
Long-Term Debt Repaid
--1,206-1,206-1,053-923-316
Net Debt Issued (Repaid)
-1,206-1,206-1,206-553-9234,684
Issuance of Common Stock
--592,132-101
Common Dividends Paid
-165--1-1--782
Other Financing Activities
-25-21-33-39-74-44
Financing Cash Flow
-1,396-1,227-1,1811,539-9973,959

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
75-5112497682
Miscellaneous Cash Flow Adjustments
-1--1-1
Net Cash Flow
-1,472-275-7122,447-2,724823

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
360523205-404-2,058-3,071
Free Cash Flow Growth
-155.12%----
Free Cash Flow Margin
5.44%8.18%3.26%-6.60%-40.83%-27.18%
Free Cash Flow Per Share
7.1610.414.08-8.53-47.20-70.58
Levered Free Cash Flow
237.25368.75-328.25470.25721-656.63
Unlevered Free Cash Flow
239.13371.88-323.25475.25727.25-652.88

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
3588106
Cash Income Tax Paid
353430-231,030
Change in Working Capital
-225-86-8649173,0654,978